Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sodium phosphate laxative warnings, use limits to be subject of "feedback" meeting.

This article was originally published in The Tan Sheet

Executive Summary

SODIUM PHOSPHATE LAXATIVES NEW WARNINGS, USE LIMITS for both oral and rectal products are expected to be discussed at an OTC "feedback" meeting at FDA tentatively scheduled for July 15. In response to objections by the laxative manufacturers Nutramax and C.B. Fleet, the agency has agreed to a meeting on the new requirements, which were part of a May 21 final rule on sodium phosphate laxatives ("The Tan Sheet" May 25, p. 9). Among the companies' objections is that the warnings and directions for both types of products required by the rule were not previously proposed by the agency and therefore not subject to prior notice and comment as required by the Administrative Procedures Act.
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS088633

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel